Conversely, the knockdown of RUNX2 in triple-negative BC cells leads to a decrease in these glycolytic markers and an increase in pyruvate dehydrogenase-A1 (PDHA1) mRNA and enzymatic activity, indicating a reduction in glycolytic potential. This evidence concerns the gene RUNX2 and breast cancer.